EverSource Wealth Advisors’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58K Buy
370
+222
+150% +$1.24K ﹤0.01% 3618
2026
Q1
$579 Buy
148
+96
+185% +$426 ﹤0.01% 4028
2025
Q4
$237 Buy
52
+50
+2,500% +$257 ﹤0.01% 4009
2025
Q3
$12 Sell
2
-17
-89% -$108 ﹤0.01% 4295
2025
Q2
$123 Buy
+19
New +$102 ﹤0.01% 4103
2022
Q4
Sell
-126
Closed -$2K 2419
2022
Q3
$2K Buy
126
+42
+50% +$850 ﹤0.01% 1727
2022
Q2
$2K Sell
84
-203
-71% -$4.76K ﹤0.01% 1571
2022
Q1
$8K Hold
287
﹤0.01% 1099
2021
Q4
$8K Buy
+287
New +$8.12K ﹤0.01% 1068

Other funds holding TBI

EverSource Wealth Advisors's TBI Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Trueblue (TBI) stake by 150% in Q2 2026, buying an estimated $1.24K and bringing the position to 370 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #3618.

EverSource Wealth Advisors first reported a position in TBI in Q4 2021 and has held it in 9 quarters since. The position peaked at $8K in Q1 2022. 24 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • EverSource Wealth Advisors held 370 shares of Trueblue worth $2.58K as of Q2 2026.
  • EverSource Wealth Advisors bought 222 Trueblue shares in Q2 2026, an estimated $1.24K.
  • Trueblue made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3618 holding.
  • EverSource Wealth Advisors first reported a position in Trueblue in Q4 2021 and has held it in 9 quarters since.
  • EverSource Wealth Advisors's Trueblue position peaked at $8K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.